COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.
Leonardo Santos HoffNaveen RSamuel Katsuyuki ShinjoJessica A DayParikshit SenJucier Gonçalves JúniorJames B LillekerMasataka KuwanaVishwesh AgarwalSinan KardeşMinchul KimMarcin MilchertAshima MakolTamer A GheitaBabur SalimTsvetelina V VelikovaAbraham Edgar Gracia-RamosIoannis ParodisAlbert Selva O'CallaghanElena NikiphorouAi Lyn TanTulika ChatterjeeLorenzo CavagnaMiguel Ángel Saavedra-SalinasNelly ZiadéJohannes KnitzaMasataka KuwanaAlbert Selva-O'CallaghanOliver DistlerDöndü Üsküdar CansuLisa S TrabocoR M Suryo Anggoro Kusumo WibowoErick Adrian Zamora TehozolJorge Rojas SerranoIgnacio García-De La TorreChris WincupJohn D PaulingGabriela Arredondo Hector ChinoyVikas AgarwalRohit AggarwalLatika Guptanull nullPublished in: Rheumatology international (2022)
Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs.